Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 314221 - 314240 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Lithuania | (L01FD01) trastuzumab | Zercepac 60 mg milteliai infuzinio tirpalo koncentratui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01FD01) trastuzumab | Zercepac 60 mg milteliai infuzinio tirpalo koncentratui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01FD02) pertuzumab | Perjeta 420 mg/14 ml koncentratas infuziniam tirpalui 14 ml N1 (Roche Registration GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH,Vokietija |
| Lithuania | (L01FD03) trastuzumab emtansine | Kadcyla 100 mg milteliai infuzinio tirpalo koncentratui N1 (Roche Registration GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH,Vokietija |
| Lithuania | (L01FD03) trastuzumab emtansine | Kadcyla 160 mg milteliai infuzinio tirpalo koncentratui N1 (Roche Registration GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH,Vokietija |
| Lithuania | (L01FD04) trastuzumab deruxtecan | Enhertu 100 mg milteliai infuzinio tirpalo koncentratui N1 (Daiichi Sankyo Europe GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyoEuropeGmbH,Vokietija |
| Lithuania | (L01FE01) cetuximab | Erbitux 5 mg/ml infuzinis tirpalas 20 ml, N1 (Merck Europe B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | MerckEuropeB.V.,Nyderlandai |
| Lithuania | (L01FE02) panitumumab | Vectibix 20 mg/ml koncentratas infuziniam tirpalui 20 ml N1 (Amgen Europe B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V.,Nyderlandai |
| Lithuania | (L01FE02) panitumumab | Vectibix 20 mg/ml koncentratas infuziniam tirpalui 5 ml N1 (Amgen Europe B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V.,Nyderlandai |
| Lithuania | (L01FF01) nivolumab | OPDIVO 10 mg/ml koncentratas infuziniam tirpalui 10 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
| Lithuania | (L01FF01) nivolumab | OPDIVO 10 mg/ml koncentratas infuziniam tirpalui 10 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
| Lithuania | (L01FF01) nivolumab | OPDIVO 10 mg/ml koncentratas infuziniam tirpalui 24 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
| Lithuania | (L01FF01) nivolumab | OPDIVO 10 mg/ml koncentratas infuziniam tirpalui 24 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
| Lithuania | (L01FF01) nivolumab | OPDIVO 10 mg/ml koncentratas infuziniam tirpalui 4 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
| Lithuania | (L01FF01) nivolumab | OPDIVO 10 mg/ml koncentratas infuziniam tirpalui 4 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
| Lithuania | (L01FF02) pembrolizumab | Keytruda 25 mg/ml koncentratas infuziniam tirpalui 4 ml N1 (Merck Sharp & Dohme B.V., Nyderlandai) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeB.V.,Nyderlandai |
| Lithuania | (L01FF02) pembrolizumab | Keytruda 25 mg/ml koncentratas infuziniam tirpalui 4 ml N1 (Merck Sharp & Dohme B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeB.V.,Nyderlandai |
| Lithuania | (L01FF03) durvalumab | IMFINZI 50 mg/ml koncentratas infuziniam tirpalui 10 ml N1 (AstraZeneca AB, Švedija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB,Švedija |
| Lithuania | (L01FF03) durvalumab | IMFINZI 50 mg/ml koncentratas infuziniam tirpalui 10 ml N1 (AstraZeneca AB, Švedija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB,Švedija |
| Lithuania | (L01FF04) avelumab | Bavencio 20 mg/ml koncentratas infuziniam tirpalui 10 ml N1 (Merck Europe B.V., Nyderlandai) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckEuropeB.V.,Nyderlandai |
Pages
